A study about low blood pressure in patients with primary immunodeficiency disease treated with immune globulin products.

• Primary immunodeficiency is a condition that impairs the immune system
• Many people with PID receive immunoglobulin treatment as a replacement therapy
• This observational study aims to compare any side effects between Bivigam® and other products

Study Benefits

• Contribute to bettering immunoglobulin treatment and decreasing potential side effects
• Purely observational -you would be coming in for your infusion as normal and we simply observe your vitals during and after your infusion.
• You will on be asked to change dose or type of immunoglobulin.

Study Volunteers Must Meet the Following Criteria

• Any age – male/female
• Must have PID diagnosis

Study Participant Expectations

• 6 Infusions

Cost

• There is no cost to participate. Patients who qualify may be compensated for time and travel up to $40 per infusion